A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function
Jeremy To et al. develop an ultra-high-content assay platform used to interrogate T-cell-mediated killing of 3D multicellular tumor spheroids. They screen 1,800 annotated compounds to identify small molecules that enhance cytotoxic CD8+ T-cell activity in an antigen-dependent manner, demonstrating t...
Guardado en:
Autores principales: | Jeremy To, Doug Quackenbush, Emily Rowell, Lilin Li, Connor Reed, Frederick Lo, Shane R. Horman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2fe4f359c6846cb9abcd2c93d669558 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Retraction Note: A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function
por: Jeremy To, et al.
Publicado: (2021) -
An experimental biomimetic platform for artificial olfaction.
por: Corrado Di Natale, et al.
Publicado: (2008) -
Genetic and pharmacological interrogation of cancer vulnerability using a multiplexed cell line screening platform
por: Yifeng Xia, et al.
Publicado: (2021) -
A biomimetic engineered bone platform for advanced testing of prosthetic implants
por: Martina Sladkova-Faure, et al.
Publicado: (2020) -
Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy
por: Wu M, et al.
Publicado: (2019)